The mechanism of bleomycin in inducing haemangioma regression

dc.contributor.author	Mabeta, Peaceful Lucy
dc.contributor.author	Davis, P.F.
dc.date.accessioned	2008-09-25T09:45:30Z
dc.date.available	2008-09-25T09:45:30Z
dc.date.issued	2008-07
dc.description.abstract	Haemangiomas are neoplasms of the vasculature frequently encountered in paediatrics which, although benign, may present with serious complications. The potential beneficial effects of intralesional bleomycin injection (IBI) in the treatment of haemangiomas were initially reported by Kullendorf and Sarihan et al.	en_US
dc.description.sponsorship	This study was funded by National Research Foundation and Bristol-Myers Squibb	en_US
dc.identifier.citation	Mabeta, P & Davis PF 2008, ‘The mechanism of bleomycin in inducing haemangioma regression’, South African Medical Journal, vol. 98, no. 7, pp. 538-539. [www.samj.org.za]	en_US
dc.identifier.issn	0038-3469
dc.identifier.other	G-9725-2014
dc.identifier.other	12791859400
dc.identifier.uri	http://hdl.handle.net/2263/7357
dc.language.iso	en	en_US
dc.publisher	Health and Medical Publishing Group	en_US
dc.rights	Health and Medical Publishing Group	en_US
dc.subject	Haemangioma	en_US
dc.subject	Neoplasms	en_US
dc.subject.lcsh	Pediatrics
dc.subject.lcsh	Hemangiomas
dc.subject.lcsh	Bleomycin
dc.title	The mechanism of bleomycin in inducing haemangioma regression	en_US
dc.type	Article	en_US